Period
recent search
Showing: 1 – 05 of 156 Regulated Information
06 July 2022
06 July 2022
LinkedIn
Facebook
Half-year statement of IPSEN liquidity agreement with NATIXIS ODDO BHF
This article or press release has no online content. Please download the associated documents for more information.
06 July 2022
06 July 2022
LinkedIn
Ipsen – Half year statement – 2022 06 30
This article or press release has no online content. Please download the associated documents for more information.
05 July 2022
05 July 2022
LinkedIn
Share buyback program – Ipsen reporting from 27 june to 01 July 2022 – Agrege
This article or press release has no online content. Please download the associated documents for more information.
28 June 2022
28 June 2022
LinkedIn
Share buyback program – Ipsen reporting from 20 june to 24 June 2022 – Detailed
This article or press release has no online content. Please download the associated documents for more information.
27 June 2022
27 June 2022
LinkedIn
Ipsen to acquire Epizyme, expanding its portfolio in oncology
PARIS, FRANCE & CAMBRIDGE, MASSACHUSETTS, 27 June 2022 – Ipsen (Euronext: IPN; ADR: IPSEY) and Epizyme (Nasdaq: EPZM) today announced that they have entered into a definitive merger agreement under which Ipsen will acquire Epizyme. The transaction was unanimously approved by…